Cadiomyogenesis of human mesenchymal stem cells

Posted: Published on August 15th, 2011

This post was added by Dr. Richardson



Marrow-derived human mesenchymal stem cells (hMSCs) have short proliferative longevity, compared with embryonic stem cells, and thus, important challenge in regenerative medicine is to improve the replicative capacity of human hMSCs.

See the article here:
Cadiomyogenesis of human mesenchymal stem cells

Related Posts
This entry was posted in Mesenchymal Stem Cells. Bookmark the permalink.

Comments are closed.